Back to Agenda
Session 10: International Regulatory Authority Updates
Session Chair(s)
Lindsay Fitzgerald
Delivery Manager
Astrix, United States
Tamei Elliott, MS
Director, Global Scientific Content
DIA, United States
Receive the latest updates from international regulators about recent and future developments. This session provides attendees the opportunity to ask regulators questions directly. Please note: due to the high volume of questions, not all will be answered live at the forum.
Kellen Cristina de Freitas Gissoni, ANVISA
Swissmedic Regulatory Update – DIA RSIDM Forum 2025 - Philipp Weyermann, Swissmedic
Karin Hay, Health Canada
International Regulatory Authority Update - Hilmar Hamann, European Medicines Agency
Learning Objective : At the conclusion of this session, participants should be able to:- Gain insights on recent updates and future developments from various global regulators
Speaker(s)
Speaker
Kellen Christina de Freitas Gissoni, RPh
ANVISA, Brazil
Health Regulation Specialist
Swissmedic Regulatory Update – DIA RSIDM Forum 2025
Philipp Weyermann, DrSc, MSc
Swissmedic, Switzerland
Head of Unit Regulatory Assessment 2
Health Canada Update
Karin Hay
Health Canada, Canada
Senior Policy Analyst
International Regulatory Authority Update – EMA
Hilmar Hamann, PhD
European Medicines Agency (EMA), Netherlands
Chief Information Officer
Have an account?